You are here: Scientific Experts > Israel > Tel Aviv University > Eldar-Finkelman > Hagit Eldar-Finkelman
glycogen synthase kinases
Tel Aviv University
Eldar Finkelman H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002;8:126-32
..Finally, selective inhibitors of GSK-3 could mimic the action of mood stabilizers such as lithium and valproic acid and be used in the treatment of bipolar mood disorders. ..
Eldar Finkelman H, Eisenstein M. Peptide inhibitors targeting protein kinases. Curr Pharm Des. 2009;15:2463-70
..In this review we focus on the strategies to design such peptide inhibitors, focusing mainly on the serine/threonine protein kinase family. ..
Licht Murava A, Paz R, Vaks L, Avrahami L, Plotkin B, Eisenstein M,
. A unique type of GSK-3 inhibitor brings new opportunities to the clinic. Sci Signal. 2016;9:ra110
..This new modality of GSK-3 inhibition may be therapeutic in patients with AD or other central nervous system disorders associated with dysregulated GSK-3. ..
Experts and Doctors on humans in Israel
Experts and Doctors on glycogen synthase kinase 3 in Israel
Experts and Doctors on bipolar disorder in Israel
Experts and Doctors on insulin resistance in Israel
Labome.Org © 2018 All Rights Researved
Princeton, New Jersey 08540, USA
last updated: February 09, 2019